Resumen
The Ontario Brain Institute's “Brain-CODE” is a large-scale informatics platform designed to support the collection, storage and integration of diverse types of data across several brain disorders as a means to understand underlying causes of brain dysfunction and developing novel approaches to treatment. By providing access to aggregated datasets on participants with and without different brain disorders, Brain-CODE will facilitate analyses both within and across diseases and cover multiple brain disorders and a wide array of data, including clinical, neuroimaging, and molecular. To help achieve these goals, consensus methodology was used to identify a set of core demographic and clinical variables that should be routinely collected across all participating programs. Establishment of Common Data Elements within Brain-CODE is critical to enable a high degree of consistency in data collection across studies and thus optimize the ability of investigators to analyze pooled participant-level data within and across brain disorders. Results are also presented using selected common data elements pooled across three studies to better understand psychiatric comorbidity in neurological disease (Alzheimer's disease/amnesic mild cognitive impairment, amyotrophic lateral sclerosis, cerebrovascular disease, frontotemporal dementia, and Parkinson's disease).
Idioma original | English |
---|---|
Número de artículo | 816465 |
Publicación | Frontiers in Psychiatry |
Volumen | 13 |
DOI | |
Estado | Published - feb. 7 2022 |
Nota bibliográfica
Funding Information:This research was conducted with the support of the Ontario Brain Institute, an independent non-profit corporation, funded partially by the Ontario government. BEAM funding from Brain Canada, the Edwards Foundation and GE Healthcare for in kind support; funding was also received from Linda C. Campbell toward the BEAM study. CAN-BIND and ONDRI are Integrated Discovery Programs with support from the Ontario Brain Institute, with funding and/or in-kind support also provided by the investigators’ universities and academic institutions. Additional funding for CAN-BIND was provided by CIHR, Lundbeck, Bristol-Myers Squibb, Pfizer, and Servier. The funder was not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication.
Publisher Copyright:
Copyright © 2022 Vaccarino, Beaton, Black, Blier, Farzan, Finger, Foster, Freedman, Frey, Gilbert Evans, Ho, Javadi, Kennedy, Lam, Lang, Lasalandra, Latour, Masellis, Milev, Müller, Munoz, Parikh, Placenza, Rotzinger, Soares, Sparks, Strother, Swartz, Tan, Tartaglia, Taylor, Theriault, Turecki, Uher, Zinman and Evans.
ASJC Scopus Subject Areas
- Psychiatry and Mental health
PubMed: MeSH publication types
- Journal Article